Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting research proposals for the funding opportunity titled "Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)." This initiative aims to enhance the understanding of trained immunity, focusing on innate immune memory and its implications for immune system development, vaccine responses, and allergic or autoimmune conditions. The program seeks to identify novel biomarkers and elucidate the mechanisms behind trained immunity, with a maximum funding amount of $275,000 available over a two-year grant period. Applications are due starting June 16, 2024, and must adhere to strict application guidelines, with no clinical trials permitted. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-111.html.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.